Additionally, Claudin-4 positive human ovarian carcinoma cells experienced a 6.7-fold elevation in toxicity when treated with a fusion of recombinant c-CPE and tumor necrosis factor (TNF) than with TNF alone [60]. The gene discussed is CLDN4; the disease is ovarian carcinoma.